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The Influence of Fibrinogen ond Fibrin on Thrombin
Generotion - Evidence for Feedbock Activotion
Rochono Kumol Suzette B6guin, H, Coenrood Hemker
From the Deportment of Biochemistry, Foculty of Medicine ond Cordiovosculor Reseorch Institute,
University of Limburg, Moostricht, The Netherlonds
of the Clotting System by Clot Bound Thrombin
Summory
In plasma the bulk of thrombin generation takes place after a clot has
formed. We therefore investigated in what way the clot influences
thrombin generation i plasma. The forming clot withdraws thrombin
from free solution. Consequently less thrombin activity is found and
less thrombin-inhibitor complexes are formed. The thrombin that is
adsorbed to the clot reduces the lag time before thrombin generation i
intrinsically or extrinsically triggered platelet poor plasma s well as in
platelet rich plasma. We investigated the mechanism of this activation.
Clots were obtained by recalcification of plasma or by the addition
of thrombinlike enzymes (Reptilase, Agihal) from snake venoms.
They were thoroughly washed until the washing fluid was devoid of
any detectable clotting enzyme activity. In platelet poor plasma (PPP),
thrombin-induced clots shorten the factor Va-dependent lag-time of
thrombin generation i the extrinsic system as well as the factor \rIIIa-
dependent thrombin generation in the intrinsic system. FactorV or
factor VII preparations that in itself hardly influence thrombin genera-
tion patterns aquire the capacity to shorten these lag-times when
incubated with clot. The last washing fluid of the clot is inactive.
Snake venom induced clots are not active either. Clots that are incubat-
ed in heparinised plasma for I h or more are as active as clots from
normal plasma re. A role of factor Xa can not be excluded but must be
minor because a clot made by addition of thrombin to plasma from
which the factors II. VII. X and X have been removed is as active as a
clot from normal plasma is.
When added to recalcified platelet rich plasma (PRP), in which the
lag{ime of thrombin formation is dependent upon activation of platelet
procoagulant phospholipid activity, any type of clot shortens the lag-
time before the burst of tlrombin generation. Clots that are obtained by
snake venom enzymes are also active in this system. This indicates that
fibrin alone is capable to induce the procoagulant phospholipid activity
in platelets.
We conclude that tlree known thrombin-dependent feedback activa-
tions in the clotting system (factor V, factor VIII and platelets) are effi-
ciently supporled by thrombin bound to the fibrin clot and that there is
an additional activating effect of fibrin on the procoagulant action of
olatelets.
Conespondence to:Dr. S. B6guin, Faculty ofMedicine and Cardiovascular
Research Institute, Depafiment of Biochemistry, University of Limburg,
P.O. Box 616, N-6200 MD Maastricht, The Netherlands - FAX Number:
+3 I 43 6709 88
Inlroduclion
The clotting of fibrinogen by thrombin is caused by the enzymatic
removal of fibrinopeptides A and B (1). In this process thrombin is
adsorbed on the fibrin (2-6). This propefiy of fibrin is known as Anti-
thrombin I action (7). The clot bound thrombin remains enzymatically
active, as has been shown by its ability to release FPA from fibrinogen
(8-10), to clot fibrinogen, to induce the platelet release reaction (10)
and to hydrolyse chromogenic substrate 52238 (9). It also has been
reported that a washed clot will shorten the coagulation time of blood
and plasma (10, 11). It is the purpose of this article to investigate the
mechanism(s) by which clot bound thrombin influences thrombin
generation i plasma.
The inhibition characteristics of clot bound thrombin are reportedly
different from those of free thrombin in that it seems protected from
inactivation by antithrombin III (AT III) even in the presence of
heparin (5) but remains accessible to antithrombin Ill-independent
inhibitors like hirudin, hirudin dodecapeptide (Hirugen), D-Phe-Pro-
Arg-Chloromethyl ketone (PPACK) (8) and Dermatan Sulphate (12).
The most ready explanation for clot induced coaguiation of plasma
is that bound thrombin clots fibrinogen from the free solution. Another
possible mechanism is that an existing clot induces thrombin genera-
tion in the sunounding plasma. Indeed the shortening of whole blood
clotting time (WBCT) has been reported when clots were incubated in
native blood (12, 1 3). Positive feedback activation, i. e. enhancement of
the rate of thrombin production by the first traces of thrombin fomed,
is an essential part 0f the clotting process (14). With the initial sequen-
tial activation of clotting factors only trace amounts of thrombin are
generated (15). These traces of thrombin have the ability to activate
factor V, factor VIII (15-20) and platelets (21,22). The activated co-
factors V and VIII increase the catalytic capacity of their partner-
enzymes (factors Xa and IXa) by several orders of magnifide (23,24).
Tlnombin action 0n platelets fosters thrombin formation by exposing
procoagulant phospholipids (22) and releasing factor V (25 and
references therein). Presumably also the interstices of a platelet
aggregate provide a niche in which the products of clotting factor inter-
action are not diluted by flow phenomena. This ensemble of positive
feedback actions of thrombin on cofactors and platelets leads to
explosive, nonlinear thrombin generation (26).
The possible positive feedback-function f clot-bound thrombin has
not been analyzed until now. In this africle we investigate whether ciot
bound thrombin enhances further thLrombin formation by sustaining the
activation of factors V and VIII as well as platelets. To this purpose we
compare the influence on thrombin generation of clots produced by
thrombin and non{hrombin enzymes. A preliminary report of this work
has been presented in1993, at the 14th ICTH congress (27).
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Moteriols ond Methods
Materials
Plasma
Normal piasma was prepared by collecting blood from healthy donors on
trisodium citrate (9:1). Platelet rich plasma (PRP) was obtained by single
centrifugation at250 x g, 15" C, 10 min, while platelet poor plasma (PPP) was
obtained by a double centrifugation at 1000 X g, 15'C, 15 min and a third
centrifugation at 23,000 X g, 4" C, t hour. PPP thus obtained was stored at
-80" c.
Factor VIII deficient plasma was obtained in the same way from a known
severe haemophilia A patient who had not received substitution therapy for
several weeks.
Depleted plasma is plasma depleted of the vitamin K-dependent coagulation
factors by mixing it with 1/5 volume of Al(OH), (257o in0.l5 M NaCl) and
incubating at 37" C for 5 min, with constant stirring. After centrifuging at high
speed in an Eppendorf centrifuge for 2 min the supematant plasma was re-
covered. It was checked that no detectable amounts of the factors II, VII, IX and
X remained. The factor V concentration was 601a and the factor VIII concen-
tation 65Vo f the original pooled plasma
Defibrinated plasma is plasma that was defibrinated by mixing with 1/50
volume of Reptilase, letting the clot form at 37" C for 10 min and keeping the
clotted plasma for additional 10 min at 0-4'C. Fibrin thus formed was dis-
carded by winding on a plastic spatula. For further details see ref. 28.
Reagents
Buffer A: 50 mM Tris HCl, 100 mM NaCl, 0.5 g/1 Bovine Serum Albumin
(BSA, Sigma), pH = 7.35. Buffer B: same as Buffer A with 20 mM EDTA,
pH = 7.9. Buffer C: 50 mM Tris HC1, 175 qrM NaCl, 0.5 gA BSA, pH = 7 '9'
The phospholipids vesicles were 20 mole% phosphatidyl serine (PS) and
80 mole% phosphatidyl choline and were prepared as previously described
(23). Chromogenic substrate used for thrombin was 52238: H-D-Phe-Pip-tug-
PNA.2 HCl. Reptilase was supplied by Laboratories Stago (Asnibres, France)
and Recombinant Tissue Factor by Baxter-Dade (Diidingen, Switzerland). The
4th International standard heparin (ISH) was obtained from the National
Bureau of Standards and Control (London). Recombinant Hirudin (Knoll AG)
was a kind gift of Dr W. Homberger. Agihal, a purified fraction of Agkistro-
don Halys Halys snake venom, that splits fibrinopeptide A from fibrinogen and
does not activate factors V, VII or platelets, was obtained from Prof. L. Yu-
kelson (Tashkent, Uzbekistan). Bovine purified factors V, VIII, IX were kindly
provided by Dr. R. Wagenvoord.
Methods
Preparation of Clots
Three different ypes of clot were produced by: recalcification of normal
plasma, adding 100 nM of ttrombin to depieted plasma nd adding Reptilase or
Agihal to normal plasma.
Normal plasma clots: Platelet poor plasma (250 pl for one clot) was co-
agulated by recalcification to a final conc. of 23 mM CaCl, in a glass tube by
adding 12 p1 of0.5 M CaC1, solution andincubation at 37'Cfor 1/z h. The clot
was wound on a plastic spatula, dried by blotting and put in human serum for
10 min. In certain experiments heparin was added to this serum to a final con-
centration of 0.1 U/ml. Subsequently, the clot was washed at least 4 times in
2 ml aliquots of Buffer A over the course of several hours to eliminate any
solubte material trapped in the clots. That no unbound tluombin remained with
the clot was checked by the absence of detectable amidolytic activity of the
last washing buffer on 52238. This means that less than 0.2 picomole of throm-
bin could have leaked from a clot into the sunounding fluid during 30 min.
T;ll:, 
washing fluid was also tested for its effect in thrombin generation
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Thrombin clots in depleted plasma were prepared by adding 10 pl of human
a-tltombin (2.5 pM) to 250 pl of plasma depleted of the vitamin K-dependent
clotting factors by AI(OH), adsorption at the same time as 12 pl of 0'5 M
CaClr.
Snake venom clots were prepared from the same volume of plasma by
adding 1/50 volume of Reptilase or Agihal. The defibrinated plasma
remaining after coagulation by the snake venoms was tested for the activity of
the clotting factors and compared to the original plasma. No activation of
clotting factors was found.
Prolongation of Clotting Time by Recombinant Hirudin
In 120 pl of plasma at 37" C supplied with PS/PC (1.1 pl fina1 conc ) and
varying conc. of hirudin (0.05 p.M-0.2 pM) coagulation was triggered with
recombinant tissue factor (final dilution 11240) in 100 mM CaClr and clotting
times were recorded. The final concentration of 0.i5 pM hirudin, extending
the clotting time from 31 s (in absence of hirudin) to 2 min 45 s, was used in
our expeflments.
Measurement of Thrombin Generation i  Plasma
Thrombin generation curves were obtained as described in detail in ref-
erences 28-30. In short, to 240 pl of normal or defibrinated plasma was added
40 p1 of Buffer A (which may contain any other required substance, .g. hiru-
din) and 20 p,l PS/PC (20 pM) The mixture was incubated at 37" C for 5 min
and coagulation was triggered with 60 pl of triggering solution. Triggering
solution A (extrinsic pathway) is recombinant tissue factor (final dilution
11240) in 100 mM CaCl, (16.7 mM final conc.). Under our conditions this
dilution of thromboplastin yields a clotting time of around 31 s in non-defibrin-
ated plasma in the absence of hirudin. This trigger is used to study factor V
activation. Hirudin (150 nM final concenfation) has to be present, as will be
discussed in the experimental section. The activation of factor VIII was studied
using trigger B (intrinsic pathway), consisting of factorXa (12nM), and
PS/PC (12 pM) and Ca2* (1.5 mM). Of this trigger 38 pl was taken in the same
pipette as 22 p.1Ca2' (250 mM) to obtain 60 pl of recalcifying trigger. In the
case of PRP, 240 p1 of plasma was diluted with 60 pl Buffer A and coagulation
was triggered with 60 p1 CaCl, to obtain 16.7 mM final concentration.
After addition of the trigger, 10 pl of reaction mixture was subsampled
at equally spaced intervals (5, 10 or 15 s) in prewarmed (37" C) cuvettes with
490 u.l of Buffer B containing 200 pM of 52238. As soon as the mixture
coagulated, the clot was wound on a small spatula nd removed. The reaction
was stopped by the addition of 300 p1 of 1 M citric acid after about wo min-
utes The optical density was read at 405 nm. The spectrophotometer as well as
the subsampling and the stopping pipette were connected to a personal com-
puter that calculated the increase of OD in time from the OD and the moment
of subsampling and stopping. From the OD/min values the amidolytic activity
was calculated by comparing with a standard calibration curye of active site
titrated human o-thrombin. The lag time of thrombin formation is defined as
the moment at which the thrombin concentration rises from a 0-5 nM level to a
10-20 nM level, because we observed that in fibrin containing plasma at the
moment of clotting the thrombin concentration anived at that 1evel.
Clots or other substances of which the influence on thrombin generation was
tested, were added to the reaction mixture 90 s after triggering coagulation
Unless otherwise indicated, tluee ciots have been used.
For ease of presentation, in cases where the only essential difference
between the curves was a shift in time, i. e. a shortening of the lag-time, we
have also rendered the results as that shortening only (Tables 2 and 3)
Measurement of the Thrombin Potential
The thrombin potential is defined as the area under the thrombin generation
curve (29). It is a measure of the amount of any substrate that the thrombin
generated can potentially convert during its existence in a free form. It has
been determined by catculation of the area under the thrombin generation
curves that we determined.
M e asurement of P rothrombin and ar-Macro globulinthr ombin Complex
Prothrombin was determined as described in ref. 28. Briefly, a 10 pl sample
was incubated for 5 min in cuvettes containing 415 pl BufferB and 50 pl
staphylocoagulase, giving a final concentration of 300 nM, i e a molar excess
of staphylocoagulase over the highest protlrombin value to be expected The
amidolytic activity that generates i due to the stoichiometric staphylocoagu-
lase-ttrombin complex formed (31) This complex has the same specific
activity on chromogenic substrate as thrombin has (28) The total amidolytic
activity was measured after addition of 52238 to a final concentration of
200 pM. In samples in which thrombin has been present he thrombin is
partitioned between its different inhibitors, antithrombin III, cq-macroglobulin
and others. The ar-macroglobulin{hrombin complex retains thrombinlike
amidolytic activity. It has 0.556 times the specific activity of thrombin under
our experimental conditions (28). The amount of total prothrombin present in
plasma sample was calculated from the total amidolytic activity minus the
activlty of thrombin complexed with or-macroglobulin as measured in sample
to which no staphylocoagulase had been added.
D etermination of Thrombin/Antithrombin lll Complex (TAT )
TAT levels were determined using an enzyme immunoassay (Enzygnost
TAT, Behring, Germany) working on the sandwich principle; 100 pl of 1/4000
diluted samples of serum were incubated for 30 min in tubes coated with rabbit
antibodies to human TAT. The tubes were washed and peroxidase-conjugated
antibodies to human ATIII were added. After a 30 min incubation, tubes were
washed again and peroxidase substrate o-phenylenediamine 2 HCI was intro-
duced in the tubes They were stored in the dark for 30 min after which the sub-
strate conversion was stopped by adding 0 5 N sulphuric acid and absorbency
measured at 492 nm. The TAT concentrations in the samples were obtained via
the reference curve provided by the manufacturer
Results
Thrombin Adsorption on the Forming CIot
The amount of prothrombin consumed uring the coagulation of
plasma was not significantly influenced by the presence 0r absence
of fibrinogen (Table 1). Nevertheless, in absence of fibrinogen, the
thrombin generation curve is significantly higher than in its presence
(Fig. 1, upper frame). The area under the thrombin{ime cuwe is 31 +
3Vo (mean t SEM, n = 10) lower in the presence than in the absence of
the forming clot. Also the amount of thrombin found in the form of
TAT complexes 0r bound to crr-macroglobulin is lower after coagula-
tion of normal plasma than after thrombin generation i  defibrinated
plasma (Table 1).
These results show that prothrombin is converled that does not
appear as amidolytic activity during thrombin generation and that is not
Table I Thrombin related variables after thrombin seneration i  normal and
defibrinated plasma
Normal Defibrinated
accounted for by the amount of TAT complexes formed or by the
amount 0f o2-macroglobulin-thrombin complexes formed. This sug-
gests that during coagulation a significant amount of thrombin is bound
to the forming fibrin clot. The phenomenon is also observed in the
presence of heparin (Fig.2). Heparin catalyses the ATlll-thrombin
interaction. The free thrombin observed istherefore lower than without
heparin, both in the presence and the absence of fibrin(ogen). The
difference between the two curves is smaller in the presence of heparin
than in its absence. This suggests that in the presence of heparin less
thrombin is adsorbed on the clot. Additional evidence for binding of
thrombin to the clot is found in the fact that a thrombin generation
curve 0f fibrin containing plasma shows a dip at the moment hat the
clot is forming in situ, which is not seen in a curve from defibrinated
plasma (Fig. 1). This can be seen clearly from the details of the first
minutes of the graph (Fig, 1, lower frame).
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Flg.1 The influence of fibrin formation on extrinsic thrombin generation.
Tluombin generation was triggered in normal pooled PPP with recombinant tis-
sue factor (11240),Ctr (16.7 mM) and phospholipids (PS/PC, 1 I pM). Ami-
dolytic activity was determined in subsamples taken at 15 s intervals. From the
amidolytic activity the thrombin activity was calculated (28) The experiment
was performed in normal plasma (I) and in the same plasma defibrinated with
reptilase (n) The difference of the two curves is represented below the time
axis (+). Lower frame: Details of the first minutes
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Fig 2 The influence of fibrin formation
presence of heparin The experiment of Fig.
0 04 IU/ml of unfracrionated heparin
(min)
on thrombin generation in the
1 was repeated in the presence of
Effect of the Clot on the Coagulation of Fibrinogen
That fibrin bound thrombin directly attacks fibrinogen has been
proven by the demonstration of clotdependent generation of fibrino-
peptides (8-10). This is not 1ikely to be a sufficient explanation for the
procoagulant effect observed, because newly formed fibrin would soon
build a considerable diffusion banier that will prevent he access of
further fibrinogen to the bound thrombin. We have tried to induce co-
agulation of non-recalcified notmal plasma by the addition of normal
clots. If the clots were well washed and incubated in serum, such as was
our standard procedure for making them, no coagulation was ever
observed in 12 out of 12 experiments even after t h. So indeed the bulk
of fibrinogen remains unconverted.
Effect of the Clot on Factor V Activation
To investigate the possibility that clot bound thrombin can mediate
feedback activation of factor V in clotting plasma, we needed asystem
in which factor VIII was guaranteed toplay no role. Therefore we used
extrinsic thrombin generation measurements canied out in factor VIII
deficient plasma.
Reinforcement of feedback activation reactions in the generation of
thrombin show as shortening of the lag-time before the burst of throm-
bin occurs, inhibition of the feedback activation causes prolongation of
tlre lagtime (I4,32,33). However, no perceptible lag-phase is seen in
extrinsic coagulation (34) not even at small time resolutions and 1ow
(up to 1/4000 diluted) thromboplastin concentrations. A delay of
thrombin generation can however be induced by hirudin. It has been
shown to be caused by retardation of the feedback activation of fac-
tor V by thrombin (35)
We observed that addition of clots to the system shortens this
hirudin induced elay (Fig. 3). This must be attributed to the clot caus-
ing prothrombinase activity. In pdnciple any of the three components
of prothrombinase, i. e. factor Xa, factor Va or procoagulant phospho-
lipids may be provided by the clot. Factor Xa activity indeed has been
demonstrated to be contained in the clot (36). We observed that clots,
produced by addition of thrombin (100 nM) to plasma devoid of factors
il, VII, IX and X, did cause shoftening of the delay (Table 2). This
shows that factor Xa is not required for the observed shortening It has
716
Timc (min)
0 5 1 0
Timc (mln)
Flg. 3 Effect ofplasma clots on extrinsic thrombin generation i defibrinated
factor VIII deficient plasma. The experimental setup was the same as in Fig. 1,
0.15 pM hirudin was added to induce a 1ag-phase Upper frame: (n) control
without hirudin; (X) control; (l) normal clots added at t = 90s; (+) 10nM
factor Va added at t = 90 s Lower frame: (n) control; (X) control plus 10 nM
factor V added; (+) control plus 10 nM factor V prevtously incubated with
normal clots and Ca2* (5 mM; (f) as the previous one but with clots pre-
incubated in heparinised serum A11 additions were done at t = 90 s (anow)
been shown before that during the initial phase of the reaction (i. e.
before the thrombin burst akes place), in the extrinsic system under our
conditions factor Xa is present in excess over factor Va (37). This
makes it very unlikely that factor Xa activity from the normal clot
would be the rate limiting reactant that shoftens the lag time.
The only phospholipids that could be present in the clots are the
traces that may be present in the normal PPP from which the clots
were made. In the thrombin generation experiments phospholipids are
added to a final concentration >1 pM. Therefore possible phospholipid
concentrations in the clots are several orders of magnitude lower and
cannot influence thrombin generation any further than the added phos-
pholipid does. It therefore is also highly unlikely that the clots con-
tribute to the prothrombinase action by bringing phospholipids to the
reaction mixture. This left factor V activation as the most likely cause
of the advancement of the thrombin burst. We therefore attempted t0
demonstrate factor V activation by the clots.
=g
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In the first place we saw that the effect of a clot can be mimicked by
the addition of factorVa (10nM final concentration) whereas non-
activated factorV has no activity (Table2). Then we showed that
non-activated factor V in which 3 clots were incubated (10 min, 37" C,
5 mM Ca2+) and then discarded, has a similar effect as activated factor
V has (Fig. 3, iower frame). The factor V preparation used or buffer
into which clots had been incubated, as well as the factor V preparation
incubated with reptilase clots were all inactive.
Incubating clots for several hours in serum to which 0.1U/ml of
heparin is added did not diminish their activity. When factor V was
preincubated with clots formed by reptilase the lag phase was nol
shortened. Clot induced factor Va generation was also measured i-
rectly, in normal plasma s well as in plasma depleted of the vitamin K-
dependent clotting factors. The plasmas were recalcified at t = 0 and
clots were added at t = 90. Every minute 10 pl aliquots were drawn and
diluted 200-fold in tubes on ice, containing Buffer C with 0.1 U/rnl of
heparin and 5 mM CaClr. From these tubes 10 pl aliquots were trans-
fened to prewarmed cuvettes containing 105 pl of buffer C and an
excess of constituents of prothrombinase [human factor Xa, 20 pM,
PS/PC 10 pM, and CaCl, 5 mM (final conc.)1. After 1 rnin, 10 pl of
human prothrombin (200 nM final conc.) was added. At 3 nin, 350 pl
of Buffer B was added to stop thrombin generation. Then tltombin was
measured via its amrdolytic activity on 52238 (see Methods). The
amount of Va generated was calculated by reading on a standard curve
generated by titration of purified factor Va with active site titrated
factor Xa in the presence of phospholipid, The results show that in
normal plasma  tremendous increase in factor Va occurs (Fig. 4, top),
this coincides with the burst of thrombin. This is to be expected
because factor Va causes thrombin formation, but freshly generated
thrombin activates factor V. It was impossible to analyse this type of
curve in terms of the precise temporal relationships between the rise of
both activities. In order to demonstrate that clots directly activate factor
V in a plasma medium, we repeated the experiment in plasma from
which the vitamin K-dependent factors had been removed. It was seen
(Fig. 4, lower frame) that normal clots are capable t0 activate traces of
factor V. The effect in itself is modest. To demonstrate factor V activa-
tion more convincingly the depleted plasma was supplied with additio-
nal factor V (70 nM) and indeed an enhancement i  Va concentration
could be seen (Fig. 4, lower frame). The bulk of factor Va generation i
normal plasma must be considered tobe secondary totlrombin forma-
tion. The importance of the small activation of factor V by the clot is
that it starts a positive feedback loop by causing the generation of
traces of free thrombin that in their tum cause further factor V activa-
tion. The effect of clots that had been incubated in heparinised serum
(0.1 U/ml) for over t h was identical to that of clots from normal
plasma.
Effect of the Clot on Factor VIII
When thrombin generation is initiated with incomplete tenase (con-
taining IXa, PS/PC and Ca2+) instead of tissue factor, clotting occurs via
the intrinsic pathway but the contact phase is short circuited (32). AIag
phase is always observed, because initial traces of thrombin have to
activate factor VIII in order to induce the thrombin burst (32, 31,38).
The effect of various types of clot on these factor VIII dependent lag
times are completely comparable to those obtained in a factor V
dependent systen (Fig. 5, Table 3). We interpreted that, analogously to
factor V, factor VIII is aiso activated by thrombin adsorbed on a clot. In-
deed, preincubation f a factor VIII preparation (15 nM in 1 mM CaClr)
with 3 clots for I min at3l" C under gentle stirring, induces the capaci-
Table 2 Shortening of hirudin induced lag time in extrinsic thrombin genera-
tion on different additions
Addition Shortening of the
lag phase (s)
None
Clot from recalcified plasma
Thrombin-clot in FII, FVII, FIX and
FX depleted plasma
Reptilase or Agihal clot
Factor V
Thrombin activated factor V
Factor V preincubated with normal clots
Factor V preincubated with reptilase clots
Factor V preincubated with PPACK clots
Factor V preincubated with last washing fluid
The lag times were obtained from tluombin generation expenments as in Fig. 3
The addition was always done at t = 1.5 min. Each experiment was repeated
4 to 6 times. No statistics were done but the range of results is given. NS indi-
cates that the difference of lag time measured was less than the sampling inter-
va l , i  e  30s .
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Fig 4 The influence of normal plasma clots on factor Va generation i  plas-
ma The development of activated factor V was measured in defibrinated nor-
ma1 pooled plasma, in subsamples taken at 1 min intervals after recalcification
and simultaneous addition ofthree normal clots. Upper frame: (I) control with-
out clots; (A) clots added at zero time Lower frame: (l) clots added at t = 0 to
plasma depleted of factors II, VII, IX and X; (A) idem with additional factor V
(70 nM) See text for experimental details
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Fig.5 Effect of plasma clots on intrinsic thrombin generation. Thrombin
generation was measured in defibrinated normal pool plasma lt was triggered
with Ca2+, factor IXa and phospholipids (incomplete t nase) as described in the
methods ection All additions were done at t = 90 s. Upper frame: (I) control;
(A) normal plasma clots added; (x) reptilase clots added Lower frame: (I)
control; (A) addition of factor VIII, 10 pl of a 15 nM solution in 1 mM CaCl,
in which 3 normal clots were incubated at 37" C for 1 min; (x) the same but
factor VIII not incubated with clots
Table 3 Shortening of the 1ag time in intrinsic thrombin generation on dif-
ferent additions
Addition Shortening of the
lag phase (s)
Flg.6 Effect of clot addition on thrombin generation canied out in piatelet
rich plasma. Thrombin generation was triggered in PRP from a notmal donor
by addition of Ca2* (16.7 mM). All additions were done at t = 90 s (anow)
Upper frame: (l) control; (n) normal plasma clots added; (X) addition of
clots incubated in serum plus 0.1 U/ml of heparin. Lower frame: (l) control;
(!) reptilase clots added; (x) addition of thrombin clots from plasma depleted
in factors II. VII, IX and X
ty to shorten the lag time, as did thrombin activated factor VIII (Fig. 5,
lower frame). The factor VIII preparation itself or buffer into which
clots had been incubated as well as the factor VIII preparation i cubated
with reptilase clots were all inactive. Again clots incubated (1 h) in
heparinised serum (0.1 U/ml) were as activo as normal clots were.
Activation of Platelets by the CIot
In PRP triggered with Ca2* there is a prolonged lag-phase to the
thrombin burst that has been shown to be caused by the time required
for the platelets to provide the necessaty procoagulant phospholipid
surface under influence of traces of thrombin formed (30). The addition
of a clot again shortens this lag time of the thrombin burst, also when
the clot has been incubated for t h in heparinised serum (Fig' 6, top).
The interesting and unexpected finding however was that any ciot, also
clots formed by reptilase and Agihal, that are inactive in platelet free
systems, horten the lag phase in PRP like a tluombin induced clot does
(Fig.6, bottom). It thus seems that the presence of thrombin adsorbed
None
Clot from recalcified plasma
Clot by thrombin in depleted plasma
Snake venom clot
Factor VIII
Thrombin activated factor VIII
Factor VIII preincubated with normal clots
Factor VIII preincubated with reptilase clots
Factor VIII preincubated with PPACK clots
Factor VIII preincubated with last washing fluid
The lagtimes were obtained from thrombin Seneration experiments as in Fig 4
Each experiment was repeated 4 to 6 times. No statistics were done but the
range of results is given. All additions were done at t = 1 5 min, NS indicates that
the difference oflag time measured was less than the sampling interval, i e 30 s
7 1 8
NS
Il-134
9'7-l2l
NS
NS
128-t47
98-1 13
NS
NS
NS
Tlme (mln)
on the clot is not an essential requirement in the case of piatelet activa-
tion, in other words that fibrin alone is capable to induce procoagulant
activity in platelets.
Discussion
The fact that a clot, even hours after it has been formed, induces
further coagulation ofplasma, is known since the 19th century. In fact
it was this observation that led Buchanan to postulate the existence of
thrombin (13). The phenomenon is presumably not without importance
for the pathophysiology of thrombosis, because it may well be a model
of one of the mechanisms of in vivo thrombus growth. Thrombus
growth is one of the major problems in the management of thrombosis,
so clot induced coagulation and its inhibition by antithrombotic drugs
deserves detailed attention.
That thrombin adsorbs onto fibrin during coagulation isknown from
the literature (see Introduction) and it also appears from Fig. 1, in which
it is seen that, from the moment on that a clot forms the amount of free
thrombin in triggered efibrinated plasma is significantly hrgher than in
non-defibrinated (i. e. normal) plasma, In the presence of heparin the
amounts of free thrombin detected are generally lower, due to the
increased scavenging of thrombin by AT III. Also the difference
between the curues in the presence and in the absence of thrombin is
smaller, which means that less thrombin is adsorbed on the clot. In the
presence of heparin the competition between fibrin and AT III for free
thrombin evidently shifts in favour of AT III. Even if AT III (-heparin)
is unable to inhibit thrombin that is bound to fibrin. it will cause less
thrombin to be bound to fibrin during the coagulation process. Hypo-
thetically this could be a beneficial effect of heparin prophylaxis and
ffeatment. Our experiments confirm that heparin does not in any way
inhibit the activity of thrombin once it is adsorbed to the clot.
From Table 1 it can be seen that the difference between thrombin
generation i the presence and in the absence of fibrin(ogen) cannot be
explained by a lack of prothrombin conversion. It is also seen in this
table that the level of the main thrombin-inhibitor complexes (TAT and
orM-thrombin) that form in the presence of fibrin are lower than in
non-defibrinated plasma. Evidently clotting fibrinogen competes for
free thrombin with the other physiological inhibitors in an ineversible
process. This is also seen when heparin is present (Fig.2). The ques-
tion of how fibrin competes with antithrombin III in absence and in
presence of heparin is at present under furlher investigation in our
laboratory.
In order to investigate the action of a clot on the clotting system in
more detail we prepared clots by recalcification of normal PPP in a
glass tube ("normal clots"). By using the intrinsic pathway without
adding an other trigger than recalcification we prevented the presence
of exogenous procoagulant substances such as kaolin, phospholipids or
tissue factor. In order to inhibit free thrombin, all clots were incubated
for 10 to 30 min in serum, in some experiments spiked with heparin
(0.1 U/ml). We observed that well washed clots that were left in their
serum for 10 minutes or more never induced coagulation i plasma that
was not recalcified. This in our opinion excludes the possibility that sig-
nificant free thrombin is contained in our clots and it also shows that
bound thrombin does not act on the great mass of fibrinogen in a solu-
tion. Probably the bound thrombin causes ome fibrin formation at
the clofsolute interface, otherwise the fibrinopeptide generation by
washed clots (8-10) is difficult to explain.
We also made clots by addition of 100 nM of thrombin to plasma
depleted of the vitamin K-dependent clotting factors by A(OH)3
adsorption. These clots ("depleted plasma clots") have been introduced
because they will not contain factor Xa. This factor has been shown to
be contained in clots from normal plasma (36). Factor Xa can activate
factors V (39, 40) and VIII (41,42), be it that factor V activation by
factor Xa has only been demonstrated in purified systems and in the
presence of phospholipids, and that, in plasma, thrombin may still be
considered tobe the only effective activator offactors V and VIII (19).
It nevertheless was necessary totest clots without factor Xa, because it
has been reported that clots contain factor Xa which would be able to
activate prothrombin (36). In clots made of depleted plasma factor Xa
cannot be present.
A third type of clots ("snake venom clots") were made by the addi-
tion to plasma of non{hrombin fibrinogen clotting enzymes from
Bothrops Atrox (Reptilase) or Agkistrodon Halys Halys(Agihal). It was
checked that both snake venom fractions, at the concentrations u ed,
do not activate factors V and VIII or platelets. Also we made "reptilase
clots" from plasma depleted of the vitamin K-dependent clotting
factors by A1(OH)3 adsorption. No differences were ever found
between the clots made by the different snake venoms, nor between
snake venom clots from normal and from depleted plasma.
Clots and Intrinsic Coagulation, the Activation of Factor VIII
In the intrinsic system triggered with factor IXa and phospholipid
a lag-phase isalways een to precede aburst of thrombin formation. We
have previously shown that this lag represents he time necessary for
traces of thrombin to activate sufficient factor VIII (32, 37, 38). Short-
ening of the lag-time therefore can be interpreted in terms of factor
VIIIa formation if short circuiting by activation of a factor on a lower
level can be excluded. The fact that factor IXa is an efficient rigger and
that no thrombin generation isseen before 12 min if only phospholipids
and Ca2* are added excludes uch a short circuit. The key observation
was that thrombin induced clots shorten the lag time whereas venom in-
duced clots do not (Fig. 5, Table 2). The fact that clots from depleted
plasma ct like normal clots do, shows in addition that factor Xa is not
likely to play a role in the shorlening mechanism. As a positive control
we added thrombin activated factor VIII, which shofiened the lag{ime
whereas the same factor VIII preparation when not activated by throm-
bin did not. Thrombin clots, also when incubated in heparin containing
serum 0r when produced by adding thrombin to depleted plasma, in-
duced activity in the factor VIII preparation that was comparable tothat
caused by free thrombin.
Clots and Extrinsic Coagulation, the Activation of Factor V
It is an as yet unresolved problem why factor V activation does not
cause a similar lag phase in extrinsic oagulation as factor VIII activa-
tion does in the intrinsic pathway. Diminished thrombin production,
such as seen in orally anticoagulated plasma does induce such a lag-
phase. Enhanced thrombin inactivation, such as induced by heparin
does not. This is reflected by the well known fact that oral anticoagula-
tion prolongs the thromboplastin time whereas heparin administration
does not. This suggests that, in extrinsic thrombin generation, there
exists a form of thrombin that is capable of activating factor V whereas
it is not inhibited by ATIII-heparin. Meizotlrombin has been shown to
be insensitive to the action of heparin (43). It will remain bound to the
phospholipid surface because it still contains the C{erminal part ofpro-
thrombin through which the molecule binds to negatively charged
phospholipids. The feedback activation therefore could take place at the
phospholipid surface. This problem is at present under investigation i
our laboratory. The natural explanation of the existence of a lag time in
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the intrinsic system then would be that factor VIII, unlike factor V,
remains in the fluid phase, i,e. cannot enter the "compartment"
because it is bound to von Willebrand factor.
To investigate the clot induced activation of factor V we had to
induce a lag time in the extrinsic system The additron of hirudin does
cause such a lag-time in the extrinsic system, probably because hirudin
does inhibit meizothrombin. It has been shown before (35) that this
lag-phase is caused by retardation of thrombin generation and not by
immediate inactivation of normally formed thrombin, we checked this
previous result by incubating samples taken at the end of the lag-time
with staphylocoagulase, they invariably developed an amidolytic
activity 0f >85% of the mixture at t = 0, in accordance with the earlier
results. We used factor VIII deficient plasma in order to rule out any
side effects via the intrinsic pathway.
We found essentially the same results as with factor VIII and 
'the
intrinsic system: again thrombin induced clots shorten the lag time
whereas venom induced clots do not. This in itself shows nothing more
than enhancement of prothnombinase activity at an earlier moment than
in the absence of a clot. which can in theory be due to any component
of the prothrombinase complex. It is unlikely however that it should be
due to factor X activation because it has been shown that under our
experimental conditions. dunng the lag phase, factor Xa is present in
large excess over factor Va (34). Also it is not like1y that phospholipids
are supplied by the clot (see above). Anyhow, in that case there would
be no reason for the difference between thrombin induced and venom
induced clots.
Elevating the concentration f factor V in plasma did not change the
lag{ime. However when the factor V preparation was incubated with
the clots and then added to the plasma without the clots, marked
shortening could be again observed.
The generation of factor Va by addition of a thrombin induced clot
could be demonstrated in normal plasma nd in plasma depleted of clot-
ting factors II, VII, IX and X. The burst of factor Va production in nor-
ma1 plasma is in all probability secondary to thrombin generation, but
factor Va generation i  depleted plasma can only be explained by a
direct action of the clot on factor V.
We conclude that the thrombin adsorbed on a clot during its formati-
on but not the fibrin itself enhances prothrombinase activity via the ac-
tivation of plasmatic factor V. Heparin is neither able to inhibit throm-
bin present on a clot nor to prevent thrombin to adsorb on a
forming clot.
The Activation of Platelets
We have previously shown that thrombin generation in PRP is
critically dependent upon the phospholipids exposed by thrombin
activation of the platelets (30), in other words that the lag{ime in
clotting PRP is the time necessary for traces of thrombin to make the
platelets expose procoagulant phospholipids. The negatively charged
phospholipids, in practice mostly phosphatidyl serine, are normally
practically exclusively present in the inner leaflet of the platelet plasma
membrane and therefore not exposed to plasma. Bevers et al. have
demonstrated that platelets dispose of a mechanism, thus far unique to
these cells, that causes a transbilayer movement of the PS to the out-
side of the activated platelet, he "flip-flop" mechanism (22). Also is PS
exposed in microvesicles shed by activated platelets (44, 45). It has
been shown that in isolated platelets thrombin and collagen are each
capable to induce the flip-flop reaction (in the presence ofCa2*) but that
the combination of the two is much more potent han each of the two
alone (22).In PRP however we found that tirombin alone is capable to
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cause a maximal procoagulant effect and that the addition of collagen
does not significantly increase the procoagulant response (30).
Rather surprisingly, all clots exhibited an activating influence on the
platelets during thrombin generation in PRP, not only the thrombin
induced clots but also those clots obtained by reptilase and Agihal that
do not contain thrombin. This indicates that the flip-flop reaction of
platelets, conffary to the activation of factors V and VIII is not oblig-
atorily restricted to the presence of thrombin on the clot. One can
surmise that fibrin has a similar type of action on platelets as collagen
has. If this is true then fibrinogen would be a kind of cofactor to the
flip-flop inducing action of thrombin in plasma. This hypothesis has to
be substantiated by the demonstration f the effect of thrombin and/or
fibrinogen and/or fibrin on the transbilayer movement in isolated
platelets. Such experiments are 0n their way now in our laboratory.
" In summary: our findings demonstrate hat thrombin induced clots
initiate coagulation in plasma by activation ofplasma cofactor proteins.
This may cause generation of more thrombin at the site of a thrombus
and hence thrombus growth. The fact that heparin does not inhibit this
process may limit the usefulness of heparin as an antithrombotic. In
general, potential antithrombotics should be characterised as to their
ability to inhibit these positive feedback reactions. Even more in-
triguing that the role of clot bound thrombin in the feedback activation
of clotting factors is the activation of platelets by fibrin to which no
thrombin can be adsorbed, r. e. the collagen like action of fibrin. This
once more indicates how intricately interwoven clotting- and platelet
reactions are. On a practical level it underlines the rationale of antico-
agulation as antithrombotic therapy and suggests hat inhibitors of fi-
brin-platelet interactions would make interesting antithrombotics.
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